New research concludes that 15O-water PET can be used to assess blood flow of the right ventricle
New research concludes that 15O-water PET can be used to assess blood flow of the right ventricle At MedTrace we keep a close eye on all new scientific research related to 15O-water and we are happy to see yet again further indications of how relevant this tracer could be to cardiac diseases. The independent research […]
MedTrace is proud to sponsor The Women in Nuclear Cardiology Event at ASNC2023
MedTrace is proud to sponsor The Women in Nuclear Cardiology Event at ASNC2023 MedTrace is showcasing its technology and Phase 3 Clinical Trial at ASNC2023, The American Society of Nuclear Cardiology’s annual conference, taking place in Toronto, Ontario, Canada from September 29 through October 1. This year, MedTrace is also sponsoring the Women in Nuclear Cardiology […]
MedTrace Receives an 18 Million Euro Investment for Completion of its Phase 3 Trial
MedTrace Receives an 18 Million Euro Investment for Completion of its Phase 3 Trial The Danish pharmaceutical and medical device company MedTrace has just closed an investment round of 18.2 million euros, overperforming its target of raising 15 million. In a challenging capital market, the investors have reaffirmed their confidence in MedTrace’s goal of making […]
15O-water demonstrations at EANM’23: Experience the daily preparation and setup of MedTrace’s 15O-water automated manufacturing system
15O-water demonstrations at EANM’23: Experience the daily preparation and setup of MedTrace’s 15O-water automated manufacturing system When The Annual European Association of Nuclear Medicine Congress opens in Vienna on September 9, 2023, MedTrace is on the spot and ready to showcase its technology and present the latest from its ongoing Phase 3 Clinical Trial RAPID-WATER-FLOW. […]
MedTrace hosts 15O-water symposium for nuclear medicine professionals
MedTrace hosts 15O-water symposium for nuclear medicine professionals 15O-water: Ready for the Future. Vol. 2. The symposium, sponsored by MedTrace, will take place on September 11, 2023, in Vienna. Guests can expect to hear from some of the world’s leading experts when they present new research and share their first-hand experiences with 15O-water. MedTrace is […]
MedTrace expands patent portfolio and protects its 15O-water technology
MedTrace expands patent portfolio and protects its 15O-water technology The U.S. Patent and Trademark Office has confirmed that MedTrace’s way of producing and dosing small volumes of 15O-water with high precision to patients before a PET scan is unique, consequently granting MedTrace a patent. The new patent is a testament to the company’s impressive innovation […]
MedTrace Pharma’s Novel 15O-Water Technology Showcased at the SNMMI 2023 Annual Meeting
MedTrace Pharma’s Novel 15O-Water Technology Showcased at the SNMMI 2023 Annual Meeting MedTrace Pharma is proud to participate with a clinical booth and share the latest about its ongoing Phase 3 Clinical Trial RAPID-WATER-FLOW at this year’s Society of Nuclear Medicine and Molecular Imaging’s (SNMMI) 2023 annual conference. The company announced recently that the first […]
MedTrace Earns ISO 13485 Certification, Meeting Stringent Standards for Medical Devices
MedTrace Earns ISO 13485 Certification, Meeting Stringent Standards for Medical Devices MedTrace is now ISO 13485 certified for the company’s quality management system in medical devices. The first technical file for the medical devices Patient Kit and Patient Kit Extended has been submitted as class IIa products and is currently under review for CE marking. […]
First U.S. Patient Scanned in MedTrace’s 15O-water Phase 3 Trial
First U.S. Patient Scanned in MedTrace’s 15O-water Phase 3 Trial The first U.S. patient in MedTrace’s phase 3 clinical trial has been dosed and scanned using the company’s automated manufacturing system for producing and dosing 15O-water. The trial seeks to evaluate the use of 15O-water PET in diagnosing coronary artery disease (CAD). It is the first phase […]
New findings from Aarhus University Hospital shed light on how 15O-water PET MPI may benefit patients with bypass surgery
New findings from Aarhus University Hospital shed light on how 15O-water PET MPI may benefit patients with bypass surgery 15O-water PET MPI may be a promising way to personalize treatment for patients with a history of bypass surgery who are still experiencing chest pain. That is the short version of the conclusion in a recent […]